Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T13:36:22.214Z.
Calculation as of: 2026-10-06T13:36:22.214Z.
Quote observation: 2026-10-06T13:34:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 304a80059de762086f201eae28471a3f317e523c87af6f00839e9007cc2266bd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-11-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Precision BioSciences, Inc.
Market Cap
$175.27M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.27M
Price/OCF Ratio
N/A
TTM Avg
193.13
3Y Avg
193.13
5Y Avg
37.46
Market Cap
$171.10M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.08M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.12M
Price/OCF Ratio
N/A
TTM Avg
32.12
3Y Avg
27.16
5Y Avg
27.16
Market Cap
$158.11M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$194.51M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $175.27M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $177.91M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $172.27M | N/A | 193.13 | 193.13 | 37.46 |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.10M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $184.12M | N/A | 32.12 | 27.16 | 27.16 |
| Inogen, Inc. (INGN)vs › | $161.63M | N/A | 113.17 | 139.63 | 64.33 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.11M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $194.51M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $154.72M | N/A | 109.43 | 140.00 | 140.00 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2021-11-10 | 578.62 |
| 2021-11-09 | 532.24 |
| 2021-11-08 | 546.38 |
| 2021-11-05 | 550.90 |
| 2021-11-04 | 557.69 |
| 2021-11-03 | 564.48 |
| 2021-11-02 | 559.39 |
| 2021-11-01 | 552.04 |
| 2021-10-29 | 536.76 |
| 2021-10-28 | 540.16 |
| 2021-10-27 | 535.07 |
| 2021-10-26 | 548.64 |
| 2021-10-25 | 545.81 |
| 2021-10-22 | 545.81 |
| 2021-10-21 | 545.25 |
| 2021-10-20 | 541.86 |
| 2021-10-19 | 561.65 |
| 2021-10-18 | 552.60 |
| 2021-10-15 | 553.73 |
| 2021-10-14 | 565.61 |
| 2021-10-13 | 563.35 |
| 2021-10-12 | 573.53 |
| 2021-10-11 | 570.14 |
| 2021-10-08 | 576.36 |
| 2021-10-07 | 632.92 |
| 2021-10-06 | 622.74 |
| 2021-10-05 | 632.92 |
| 2021-10-04 | 619.34 |
| 2021-10-01 | 659.50 |
| 2021-09-30 | 652.71 |
| 2021-09-29 | 655.54 |
| 2021-09-28 | 665.72 |
| 2021-09-27 | 711.54 |
| 2021-09-24 | 714.37 |
| 2021-09-23 | 761.31 |
| 2021-09-22 | 721.72 |
| 2021-09-21 | 706.45 |
| 2021-09-20 | 701.36 |
| 2021-09-17 | 727.38 |
| 2021-09-16 | 711.54 |
| 2021-09-15 | 703.62 |
| 2021-09-14 | 684.39 |
| 2021-09-13 | 718.33 |
| 2021-09-10 | 720.02 |
| 2021-09-09 | 727.94 |
| 2021-09-08 | 714.37 |
| 2021-09-07 | 752.83 |
| 2021-09-03 | 763.01 |
| 2021-09-02 | 800.34 |
| 2021-09-01 | 774.32 |
| 2021-08-31 | 710.97 |
| 2021-08-30 | 665.16 |
| 2021-08-27 | 654.41 |
| 2021-08-26 | 614.82 |
| 2021-08-25 | 596.15 |
| 2021-08-24 | 574.66 |
| 2021-08-23 | 570.14 |
| 2021-08-20 | 532.24 |
| 2021-08-19 | 519.23 |
| 2021-08-18 | 531.67 |
| 2021-08-17 | 530.54 |
| 2021-08-16 | 537.33 |
| 2021-08-13 | 576.36 |
| 2021-08-12 | 100.87 |
| 2021-08-11 | 90.40 |
| 2021-08-10 | 88.51 |
| 2021-08-09 | 89.11 |
| 2021-08-06 | 88.94 |
| 2021-08-05 | 90.57 |
| 2021-08-04 | 85.68 |
| 2021-08-03 | 84.13 |
| 2021-08-02 | 85.25 |
| 2021-07-30 | 84.65 |
| 2021-07-29 | 85.33 |
| 2021-07-28 | 86.96 |
| 2021-07-27 | 84.56 |
| 2021-07-26 | 86.62 |
| 2021-07-23 | 87.99 |
| 2021-07-22 | 90.31 |
| 2021-07-21 | 92.20 |
| 2021-07-20 | 92.46 |
| 2021-07-19 | 90.14 |
| 2021-07-16 | 90.65 |
| 2021-07-15 | 91.60 |
| 2021-07-14 | 91.43 |
| 2021-07-13 | 93.32 |
| 2021-07-12 | 98.38 |
| 2021-07-09 | 98.47 |
| 2021-07-08 | 98.12 |
| 2021-07-07 | 98.98 |
| 2021-07-06 | 99.75 |
| 2021-07-02 | 106.11 |
| 2021-07-01 | 108.68 |
| 2021-06-30 | 107.48 |
| 2021-06-29 | 103.45 |
| 2021-06-28 | 104.22 |
| 2021-06-25 | 97.78 |
| 2021-06-24 | 96.84 |
| 2021-06-23 | 91.86 |
| 2021-06-22 | 91.34 |
| 2021-06-21 | 93.14 |
| 2021-06-18 | 90.31 |
| 2021-06-17 | 91.60 |
| 2021-06-16 | 90.91 |
| 2021-06-15 | 94.26 |
| 2021-06-14 | 99.67 |
| 2021-06-11 | 99.07 |
| 2021-06-10 | 100.87 |
| 2021-06-09 | 99.07 |
| 2021-06-08 | 100.78 |
| 2021-06-07 | 97.35 |
| 2021-06-04 | 94.43 |
| 2021-06-03 | 95.63 |
| 2021-06-02 | 97.01 |
| 2021-06-01 | 92.80 |
| 2021-05-28 | 90.40 |
| 2021-05-27 | 95.03 |
| 2021-05-26 | 92.89 |
| 2021-05-25 | 87.39 |
| 2021-05-24 | 89.28 |
| 2021-05-21 | 88.68 |
| 2021-05-20 | 87.82 |
| 2021-05-19 | 80.44 |
| 2021-05-18 | 81.56 |
| 2021-05-17 | 80.61 |
| 2021-05-14 | 81.56 |
